AKT1 and colorectal cancer: In colorectal cancer progression, it is inhibited by miRNA-33a and let-7e ST8SIA1 [113], while in prostate cancer progression, it is stimulated by the lncRNA MIR44352HG, resulting in FAK/AKT/β-catenin signaling pathway activation [114].